Water Island Capital LLC Seagen Inc. Transaction History

Water Island Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2024	BUY	$191.51 - $216.16 $15.2 Million - $17.2 Million	79,369 Added 51.47%	233,580 $49.6 Million
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $15.2 Million - $17.2 Million	79,369 Added 51.47%	233,580 $49.6 Million
Q2 2023 Nov 14, 2024	BUY	$187.64 - $206.25 $8.59 Million - $9.44 Million	45,782 Added 42.22%	154,211 $29.7 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $8.59 Million - $9.44 Million	45,782 Added 42.22%	154,211 $29.7 Million
Q1 2023 Nov 14, 2024	BUY	$127.59 - $203.08 $13.8 Million - $22 Million	108,429 New	108,429 $22 Million
Q1 2023 May 25, 2023	BUY	$127.59 - $203.08 $13.8 Million - $22 Million	108,429 New	108,429 $22 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Water Island Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Water Island Capital LLC with notifications on news.